"FDA Approves First Chikungunya Vaccine for US Adults"

The US Food and Drug Administration (FDA) has approved the world's first vaccine for chikungunya, a mosquito-borne disease that causes fever and joint pains and can be fatal to newborns. The vaccine, named Ixchiq, was developed by Valneva and will be administered in a single shot. With no specific drug currently available to treat chikungunya, the FDA's approval is expected to accelerate the vaccine's global rollout. Chikungunya cases have been on the rise, with South America and South Asia being the most affected regions. The disease can lead to severe health problems, particularly for older adults and individuals with underlying medical conditions.